Ubiquitin-dependent proteolytic control of SUMO conjugates

被引:246
作者
Uzunova, Kristina
Goettsche, Kerstin
Miteva, Maria
Weisshaar, Stefan R.
Glanemann, Christoph
Schnellhardt, Marion
Niessen, Michaela
Scheel, Hartmut
Hofmann, Kay
Johnson, Erica S.
Praefcke, Gerrit J. K.
Dohmen, R. Juergen
机构
[1] Univ Cologne, Inst Genet, D-50674 Cologne, Germany
[2] Univ Cologne, Ctr Mol Med Cologne, D-50674 Cologne, Germany
[3] Miltenyi Biotec GmbH, Bioinformat Dept, MACSmol Business Unit, D-50829 Cologne, Germany
[4] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA
关键词
D O I
10.1074/jbc.M706505200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Posttranslational protein modification with small ubiquitin-related modifier (SUMO) is an important regulatory mechanism implicated in many cellular processes, including several of biomedical relevance. We report that inhibition of the proteasome leads to accumulation of proteins that are simultaneously conjugated to both SUMO and ubiquitin in yeast and in human cells. A similar accumulation of such conjugates was detected in Saccharomyces cerevisiae ubc4 ubc5 cells as well as in mutants lacking two RING finger proteins, Ris1 and Hex3/Slx5-Slx8, that bind to SUMO as well as to the ubiquitin-conjugating enzyme Ubc4. In vitro, Hex3-Slx8 complexes promote Ubc4-dependent ubiquitylation. Together these data identify a previously unrecognized pathway that mediates the proteolytic down-regulation of sumoylated proteins. Formation of substrate-linked SUMO chains promotes targeting of SUMO-modified substrates for ubiquitin-mediated proteolysis. Genetic and biochemical evidence indicates that SUMO conjugation can ultimately lead to inactivation of sumoylated substrates by polysumoylation and/or ubiquitin-dependent degradation. Simultaneous inhibition of both mechanisms leads to severe phenotypic defects.
引用
收藏
页码:34167 / 34175
页数:9
相关论文
共 63 条
[1]   The SUMO-1 isopeptidase Smt4 is linked to centromeric cohesion through SUMO-1 modification of DNA Topoisomerase II [J].
Bachant, J ;
Alcasabas, A ;
Blat, Y ;
Kleckner, N ;
Elledge, SJ .
MOLECULAR CELL, 2002, 9 (06) :1169-1182
[2]  
Bai C, 1997, METHOD ENZYMOL, V283, P141
[3]  
Biggins S, 2001, GENETICS, V159, P453
[4]   Structure of a BRCA1-BARD1 heterodimeric RING-RING complex [J].
Brzovic, PS ;
Rajagopal, P ;
Hoyt, DW ;
King, MC ;
Klevit, RE .
NATURE STRUCTURAL BIOLOGY, 2001, 8 (10) :833-837
[5]   The SUMO isopeptidase Ulp2 prevents accumulation of SUMO chains in yeast [J].
Bylebyl, GR ;
Belichenko, I ;
Johnson, ES .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (45) :44113-44120
[6]   SUMO modifications control assembly of synaptonemal complex and polycomplex in meiosis of Saccharomyces cerevisiae [J].
Cheng, Chung-Hsu ;
Lo, Yu-Hui ;
Liang, Shu-Shan ;
Ti, Shih-Chieh ;
Lin, Feng-Ming ;
Yeh, Chia-Hui ;
Huang, Han-Yi ;
Wang, Ting-Fang .
GENES & DEVELOPMENT, 2006, 20 (15) :2067-2081
[7]   SUMO-1 modification of IκBα inhibits NF-κB activation [J].
Desterro, JMP ;
Rodriguez, MS ;
Hay, RT .
MOLECULAR CELL, 1998, 2 (02) :233-239
[8]   SUMO protein modification [J].
Dohmen, RJ .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2004, 1695 (1-3) :113-131
[9]   Complementary whole-genome technologies reveal the cellular response to proteasome inhibition by PS-341 [J].
Fleming, JA ;
Lightcap, ES ;
Sadis, S ;
Thoroddsen, V ;
Bulawa, CE ;
Blackman, RK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (03) :1461-1466
[10]   Proteasome-mediated effects on amyloid precursor protein processing at the γ-secretase site [J].
Flood, F ;
Murphy, S ;
Cowburn, RF ;
Lannfelt, L ;
Walker, B ;
Johnston, JA .
BIOCHEMICAL JOURNAL, 2005, 385 :545-550